Last year, the U.S. Food and Drug Administration approved Neffy, a nasal spray form of epinephrine for people who weigh 66 ...
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS Pharmaceuticals received the green light from health regulators for a ...
Neffy (epinephrine nasal spray) 1mg is approved for the emergency treatment of type 1 allergic reactions, including ...
Payment options are available based on insurance coverage. The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 ...
The U.S. Food and Drug Administration approved the local company’s 1 milligram dose of epinephrine nasal spray on Wednesday. It’s geared toward patients 4 years and older who weigh at least 33 ...
The US Food and Drug Administration (FDA) has approved ARS Pharmaceuticals' neffy 1mg (epinephrine nasal spray) for treating type one allergic reactions including anaphylaxis in paediatric ...
March 6, 2025 – The FDA has approved a new nose spray that can quickly treat severe ... minutes and requires emergency treatment with epinephrine. This medication helps by raising blood ...
$7.3 million in total neffy ® (epinephrine nasal spray) U.S. net product revenue in 2024 since launch in late September 2024 neffy 1 mg approved by U.S. FDA for children aged four and older and ...
Last year, the U.S. Food and Drug Administration approved Neffy, a nasal spray form of epinephrine for people who weigh 66 pounds or more, and this month it approved a lower dose spray for ...
For patients weighing 15kg to less than 30kg, the recommended dose is 1 spray of neffy 1mg. The Food and Drug Administration (FDA) has approved neffy ® (epinephrine nasal spray) 1mg for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results